Stanford Student Develops Gene Therapy for Her Own Disease

When Héloïse Hoffmann was diagnosed with facioscapulohumeral muscular dystrophy at age 13, doctors told her there was no cure. Eight years later, she's building one herself.

The Stanford bioengineering senior just received a $100,000 O'Shaughnessy Fellowship to develop a gene therapy for FSHD, the rare muscle disease she lives with every day. Her approach differs from most current research in a crucial way.

While other scientists try to shut down production of DUX4, the toxic protein causing FSHD, Hoffmann engineered a different solution. She created a protein that blocks DUX4 from activating the genes that damage muscles in the first place.

The method has already worked in patient cells, meaningfully blocking DUX4 activity in lab tests. Next, she plans to validate the technique in mouse models, bringing her one step closer to human clinical trials.

Hoffmann started this research in 2024, leading a team of eight undergraduates to a gold medal at the International Genetically Engineered Machine competition in Paris. She then secured a $50,000 grant from Stanford's entrepreneurship program to keep the work moving forward.

Her ambitions extend beyond FSHD. If successful, this blocking technique could become a platform for treating other diseases driven by harmful gene activation.

Between lab work, Hoffmann founded GenZ of FSHD, a global community empowering young patients to advocate for research. She also interned at Regeneron Pharmaceuticals working on gene therapies for muscular dystrophy, building expertise that feeds directly into her own research.

Why This Inspires

Hoffmann represents something powerful in medical research: someone who understands the disease not just scientifically but personally. She knows what's at stake because she wakes up with it every day.

Jim O'Shaughnessy, who awarded the fellowship, put it perfectly. "The people closest to a problem are often best positioned to solve it," he said.

The O'Shaughnessy Fellowships program has supported bold creators and researchers since 2023, awarding up to 20 grants annually. Hoffmann is the sixth fellow announced in 2026, joining a network of founders, investors and experts who can help turn her research into reality.

She's dedicating her life to work that matters personally and globally. Nearly 1 million people worldwide are waiting for what she might discover.